BR0109863A - Composições tópicas contendo prostaglandina e1 - Google Patents
Composições tópicas contendo prostaglandina e1Info
- Publication number
- BR0109863A BR0109863A BR0109863-2A BR0109863A BR0109863A BR 0109863 A BR0109863 A BR 0109863A BR 0109863 A BR0109863 A BR 0109863A BR 0109863 A BR0109863 A BR 0109863A
- Authority
- BR
- Brazil
- Prior art keywords
- prostaglandin
- composition
- mixture
- substituted amino
- buffer system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Abstract
"COMPOSIçõES TóPICAS CONTENDO PROSTAGLANDINA E~ 1~". é fornecida uma composição tópica de consistência semi-sólida adequada para aplicação transdérmica de prostaglandina E~ 1~. A composição compreende prostaglandina E~ 1~, um intensificador de penetração, uma goma polissacarídea, um composto lipofílico, e um sistema de tampão ácido. O intensificador de penetração de pele é um sal de adição ácida de um éster de alquil-2-(amino substituído)-alcanoato, de um (amino substituído)-alcanol alcanoato, ou de uma mistura desses. O composto lipofílico pode ser um álcool alifático C~ 1~ a C~ 8~, um éster alifático C~ 8~ a C~ 30~, ou uma mistura desses. A composição inclui um sistema de tampão capaz de fornecer um valor de pH tamponado para a referida composição na faixa de cerca de 3 a cerca de 7,4.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/542,668 US6414028B1 (en) | 1997-11-05 | 2000-04-04 | Topical compositions containing prostaglandin E1 |
PCT/US2001/010699 WO2001074279A1 (en) | 2000-04-04 | 2001-04-04 | Topical compositions containing prostaglandin e¿1? |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0109863A true BR0109863A (pt) | 2004-09-28 |
Family
ID=24164793
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0109863-2A BR0109863A (pt) | 2000-04-04 | 2001-04-04 | Composições tópicas contendo prostaglandina e1 |
Country Status (16)
Country | Link |
---|---|
US (1) | US6414028B1 (pt) |
EP (1) | EP1278495A4 (pt) |
JP (1) | JP2004514646A (pt) |
KR (1) | KR20030060769A (pt) |
CN (1) | CN1203895C (pt) |
AU (1) | AU2001249792A1 (pt) |
BR (1) | BR0109863A (pt) |
CA (1) | CA2405293A1 (pt) |
HK (1) | HK1059558A1 (pt) |
HU (1) | HUP0302452A2 (pt) |
IL (1) | IL152084A0 (pt) |
MX (1) | MXPA02009798A (pt) |
NZ (1) | NZ522363A (pt) |
TR (1) | TR200202308T2 (pt) |
WO (1) | WO2001074279A1 (pt) |
ZA (1) | ZA200208803B (pt) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6825234B2 (en) | 1998-12-10 | 2004-11-30 | Nexmed (Holdings) , Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
EA008720B1 (ru) * | 1998-12-10 | 2007-06-29 | Нексмед (Холдингс), Инк. | Применение композиции на основе простагландина для лечения расстройства сексуального возбуждения у женщин |
US20050004226A1 (en) * | 1998-12-10 | 2005-01-06 | Nexmed (Holdings), Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
US7105571B2 (en) * | 2000-01-10 | 2006-09-12 | Nexmed Holdings, Inc. | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
US6693135B2 (en) | 2000-01-10 | 2004-02-17 | Nexmed (Holdings) Incorporated | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
US6673841B2 (en) * | 2001-12-20 | 2004-01-06 | Whan In Pharm. Co., Ltd. | Alprostadil alkyl ester-containing composition for external application |
HUP0402673A2 (hu) * | 2002-02-15 | 2005-04-28 | Nexmed (Holdings), Inc. | Erekciózavar kezelésére szolgáló prosztaglandin készítmény |
GB0222522D0 (en) | 2002-09-27 | 2002-11-06 | Controlled Therapeutics Sct | Water-swellable polymers |
US6841574B2 (en) * | 2003-01-03 | 2005-01-11 | Nexmed Holdings, Inc. | Topical stabilized prostaglandin E compound dosage forms |
US20050181030A1 (en) * | 2003-01-03 | 2005-08-18 | Mo Y. J. | Topical stabilized prostaglandin E compound dosage forms |
EP1605948A1 (en) * | 2003-03-21 | 2005-12-21 | Nexmed Holdings, Inc. | Prostaglandin compositions for the treatment of erectile dysfunction |
WO2004084861A2 (en) * | 2003-03-21 | 2004-10-07 | Nexmed (Holdings), Inc. | Angiogenesis promotion by prostaglandin compositions and methods |
CN1777429A (zh) * | 2003-04-02 | 2006-05-24 | 尼克美制药控股有限公司 | 前列腺素组合物和其治疗血管痉挛的应用 |
GB0315671D0 (en) * | 2003-07-04 | 2003-08-13 | Chelsea And Westminster Nhs Tr | Improvements in or relating to organic compounds |
US20060204526A1 (en) * | 2003-08-13 | 2006-09-14 | Lathrop Robert W | Emulsive composition containing Dapsone |
WO2005051960A2 (en) * | 2003-11-22 | 2005-06-09 | Midwest Research Laboratories, Llc | Hydrocarbyl aminohydrocarbonoates and aminohydrocarbonol hydrocarbonoates as antimicrobial and antiviral agents |
GB0417401D0 (en) | 2004-08-05 | 2004-09-08 | Controlled Therapeutics Sct | Stabilised prostaglandin composition |
CA2645073A1 (en) * | 2006-03-08 | 2007-09-13 | Nuviance, Inc. | Transdermal drug delivery compositions and topical compositions for application on the skin |
GB0613333D0 (en) | 2006-07-05 | 2006-08-16 | Controlled Therapeutics Sct | Hydrophilic polyurethane compositions |
GB0613638D0 (en) | 2006-07-08 | 2006-08-16 | Controlled Therapeutics Sct | Polyurethane elastomers |
US7560489B2 (en) * | 2006-10-11 | 2009-07-14 | Nexmed Holdings, Inc. | Stabilized prostaglandin E composition |
GB0620685D0 (en) | 2006-10-18 | 2006-11-29 | Controlled Therapeutics Sct | Bioresorbable polymers |
JP5297631B2 (ja) * | 2007-11-13 | 2013-09-25 | 花王株式会社 | 皮膚外用組成物 |
NZ592300A (en) | 2008-10-03 | 2013-01-25 | Nexmed Holdings Inc | Stabilized composition for treating psoriasis |
JP5864543B2 (ja) * | 2010-05-04 | 2016-02-17 | ネクスメッド ホールディングス,インコーポレイテッド | 小分子治療剤の組成物 |
RU2633236C2 (ru) | 2011-04-07 | 2017-10-11 | Нексмед Холдингс, Инк. | Способы и композиции для лечения болезни рейно |
ITRM20120036A1 (it) | 2012-02-02 | 2013-08-03 | Robert Davis Steigerwalt Jr | Applicazione transdermica di prostaglandina e1 per il trattamento dell¿ischemia oculare. |
KR20220164506A (ko) * | 2020-03-11 | 2022-12-13 | 어드밴식스 레진즈 앤드 케미컬즈 엘엘씨 | 건강관리 제품을 위한 계면활성제 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK243084A (da) | 1983-05-26 | 1984-11-27 | Takeda Chemical Industries Ltd | Perkutane farmaceutiske praeparater til udvortes brug |
GB8416638D0 (en) | 1984-06-29 | 1984-08-01 | Beecham Group Plc | Topical treatment and composition |
US4732892A (en) | 1985-07-12 | 1988-03-22 | American Home Products Corporation | L-α-amino acids as transdermal penetration enhancers |
US4771004A (en) | 1986-08-29 | 1988-09-13 | Iprx, Inc. | Method for in vitro determination of transdermal absorption |
US4808414A (en) | 1986-09-29 | 1989-02-28 | Nelson Research & Development Co. | Amide penetration enhancers for transdermal delivery of systemic agents |
US4865848A (en) | 1987-02-26 | 1989-09-12 | Alza Corporation | Skin permeation enhancer compositions using sucrose esters |
US5082866A (en) | 1988-06-01 | 1992-01-21 | Odontex, Inc. | Biodegradable absorption enhancers |
US4980378A (en) | 1988-06-01 | 1990-12-25 | Odontex, Inc. | Biodegradable absorption enhancers |
US5534260A (en) | 1989-02-23 | 1996-07-09 | University Of Utah | Percutaneous drug delivery system |
US4973468A (en) | 1989-03-22 | 1990-11-27 | Cygnus Research Corporation | Skin permeation enhancer compositions |
JP3202777B2 (ja) | 1992-01-24 | 2001-08-27 | リンテック株式会社 | 経皮吸収促進剤及びテープ製剤 |
CN1103586C (zh) | 1993-12-13 | 2003-03-26 | 里达克药品公司 | 蔗糖酯-c20-28醇制剂 |
US6083996A (en) * | 1997-11-05 | 2000-07-04 | Nexmed Holdings, Inc. | Topical compositions for NSAI drug delivery |
US6046244A (en) * | 1997-11-05 | 2000-04-04 | Nexmed Holdings, Inc. | Topical compositions for prostaglandin E1 delivery |
US5942545A (en) * | 1998-06-15 | 1999-08-24 | Macrochem Corporation | Composition and method for treating penile erectile dysfunction |
HUP0104168A3 (en) * | 1998-08-20 | 2003-04-28 | 3M Innovative Properties Co | Spray on bandage and drug delivery system |
US6118020A (en) * | 1999-05-19 | 2000-09-12 | Nexmed Holdings, Inc. | Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate |
US6323241B1 (en) * | 2000-01-10 | 2001-11-27 | Nexmed (Holdings) Inc. | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
-
2000
- 2000-04-04 US US09/542,668 patent/US6414028B1/en not_active Expired - Lifetime
-
2001
- 2001-04-04 TR TR2002/02308T patent/TR200202308T2/xx unknown
- 2001-04-04 EP EP01923062A patent/EP1278495A4/en not_active Withdrawn
- 2001-04-04 WO PCT/US2001/010699 patent/WO2001074279A1/en not_active Application Discontinuation
- 2001-04-04 JP JP2001572026A patent/JP2004514646A/ja not_active Withdrawn
- 2001-04-04 CN CNB018103162A patent/CN1203895C/zh not_active Expired - Fee Related
- 2001-04-04 KR KR1020027013295A patent/KR20030060769A/ko not_active Application Discontinuation
- 2001-04-04 AU AU2001249792A patent/AU2001249792A1/en not_active Abandoned
- 2001-04-04 BR BR0109863-2A patent/BR0109863A/pt not_active IP Right Cessation
- 2001-04-04 HU HU0302452A patent/HUP0302452A2/hu unknown
- 2001-04-04 NZ NZ52236301A patent/NZ522363A/xx unknown
- 2001-04-04 IL IL15208401A patent/IL152084A0/xx unknown
- 2001-04-04 CA CA002405293A patent/CA2405293A1/en not_active Abandoned
-
2002
- 2002-10-04 MX MXPA02009798A patent/MXPA02009798A/es unknown
- 2002-10-30 ZA ZA200208803A patent/ZA200208803B/en unknown
-
2004
- 2004-04-06 HK HK04102458A patent/HK1059558A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ522363A (en) | 2004-12-24 |
AU2001249792A1 (en) | 2001-10-15 |
CN1203895C (zh) | 2005-06-01 |
US6414028B1 (en) | 2002-07-02 |
IL152084A0 (en) | 2003-05-29 |
MXPA02009798A (es) | 2003-05-27 |
HK1059558A1 (en) | 2004-07-09 |
EP1278495A1 (en) | 2003-01-29 |
WO2001074279A1 (en) | 2001-10-11 |
ZA200208803B (en) | 2003-12-19 |
JP2004514646A (ja) | 2004-05-20 |
KR20030060769A (ko) | 2003-07-16 |
CA2405293A1 (en) | 2001-10-11 |
HUP0302452A2 (hu) | 2003-11-28 |
EP1278495A4 (en) | 2006-03-22 |
CN1449270A (zh) | 2003-10-15 |
TR200202308T2 (tr) | 2005-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0109863A (pt) | Composições tópicas contendo prostaglandina e1 | |
BR9813945A (pt) | Composições tópicas para distribuição de prostaglandina e1 | |
BR0212352A (pt) | Composição semi-sólida, uso de uma composição de prostaglandina semi-sólida, e, composição de prostaglandina e1 | |
BR0107478A (pt) | Método para tratar a disfunção erétil em um paciente em necessidade de tal tratamento, aplicador, composição de prostaglandina e1, e, uso de uma composição | |
KR880005939A (ko) | 제약학적 활성 물질의 침투 증강용 2성분계 침투증강 조성물 | |
DE69927963D1 (de) | Gelierbare pharmazeutische zusammensetzungen | |
BRPI0408454A (pt) | composição tópica, método de tratar a ejaculação precoce, e, uso da composição | |
MY101536A (en) | Anti-inflammatory and analgesic tape for external use | |
BR9803730A (pt) | Preparados farmacêuticos de cilansetron estabilizados contra a racemização. | |
KR910700065A (ko) | 디모펜틴을 함유한 피부장애 국소 치료용 조성물 | |
ATE131031T1 (de) | Zubereitung zur topischen anwendung. | |
TW328049B (en) | Penciclover/propylene glycol composition | |
CA2442479A1 (en) | Topical compositions for prostaglandin e1 delivery | |
KR970073579A (ko) | 소염진통용 외용 겔제제 | |
KR920003969A (ko) | 항균제 겔 배합물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1990 DE 25/02/2009. |